June 2002

|
Volume 2 Issue 6

Editorial Staff

Clinical Editor
Bradley Knight, MD
Executive Editor
Laurie Gustafson
Managing Editor
Jodie Elrod
Production Manager
Alexa Flinn

Editorial Correspondence

Jodie Elrod, Managing Editor, EP Lab Digest
HMP Communications, 70 E. Swedesford Rd
Suite 100, Malvern PA 19355
Telephone: (800) 371-0791

Fax: (866) 488-8273
Email: jelrod@hmpglobal.com
Interview with James M. Sweeney,Chairman and CEO, Cardionet
Cardionet has recently developed the first mobile cardiac telemetry service, allowing real-time, heartbeat by heartbeat monitoring of patients without hospitalization. Their ECG monitoring and analysis and response for patients provides service anywh…
Diagnosis: Flutter
Patients with atrial flutter have been exposed to anticoagulation therapy, cardioversion and drug regimens to control rate and protect them from the symptoms. When these therapies grow old or are no longer effective, they look to their electrophysiol…
EP Lab Digest speaks with EP Physician Alejandro Perez Lugones, MD
It was concluded that it was equally as safe and effective in a group of patients with a left ventricular ejection fraction, averaging less than 40% as in those with normal heart function. His research was presented at this year s ACC meeting in Marc…
Sudden Arrhythmias Death Syndromes (SADS) Foundation: Saving Lives Everyday
Actually, inherited LQTS is still often undiagnosed and untreated, so the affected persons remain at risk for syncope and sudden death. Since inherited LQTS is a very treatable disorder, SADS believes it is important that both medical professionals a…
Spotlight Interview: The Georgia Heart Center
The Georgia Heart Center recently received a five-star report card rating from HealthGrades.com, Inc., reflecting the hospital s superior quality of care in its heart program. This rating places them in the top 10 percent of medical facilities nation…
A Recipe for Success in the Treatment of Atrial Flutter
The treatment of certain arrhythmia substrates sometimes requires deeper and/or wider lesions than can be created with standard radiofrequency (RF) ablation. Typical atrial flutter is one of these substrates. The ablation of typical atrial flutter re…
Clinical Trial: The Rites of Passage
Every medical device has to pass a series of tests before it can be made available for general use on human patients. This is a long, arduous process with many unknowns and potential roadblocks along the way. Making it work requires close cooperation…